Trends in Cases, Hospitalizations, and Mortality Related to the Omicron BA.4/BA.5 Subvariants in South Africa
Clinical Infectious Diseases · 2023
DOI: 10.1093/cid/ciac921 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Waasila Jassat und 19 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg, South Africa. Hauptthemen laut MEDLINE: COVID-19, Laboratory Infection. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICD, NDoH, US Agency for International Development.
Abstract (Originalsprache)
Background
In this study, we compared admission incidence risk and the risk of mortality in the Omicron BA.4/BA.5 wave to previous waves.
Methods
Data from South Africa's SARS-CoV-2 case linelist, national COVID-19 hospital surveillance system, and Electronic Vaccine Data System were linked and analyzed. Wave periods were defined when the country passed a weekly incidence of 30 cases/100 000 population. In-hospital case fatality ratios (CFRs) during the Delta, Omicron BA.1/BA.2, and Omicron BA.4/BA.5 waves were compared using post-imputation random effect multivariable logistic regression models.
Results
The CFR was 25.9% (N = 37 538 of 144 778), 10.9% (N = 6123 of 56 384), and 8.2% (N = 1212 of 14 879) in the Delta, Omicron BA.1/BA.2, and Omicron BA.4/BA.5 waves, respectively. After adjusting for age, sex, race, comorbidities, health sector, and province, compared with the Omicron BA.4/BA.5 wave, patients had higher risk of mortality in the Omicron BA.1/BA.2 wave (adjusted odds ratio [aOR], 1.3; 95% confidence interval [CI]: 1.2–1.4) and Delta wave (aOR, 3.0; 95% CI: 2.8–3.2). Being partially vaccinated (aOR, 0.9; 95% CI: .9–.9), fully vaccinated (aOR, 0.6; 95% CI: .6–.7), and boosted (aOR, 0.4; 95% CI: .4–.5) and having prior laboratory-confirmed infection (aOR, 0.4; 95% CI: .3–.4) were associated with reduced risks of mortality.
Conclusions
Overall, admission incidence risk and in-hospital mortality, which had increased progressively in South Africa's first 3 waves, decreased in the fourth Omicron BA.1/BA.2 wave and declined even further in the fifth Omicron BA.4/BA.5 wave. Mortality risk was lower in those with natural infection and vaccination, declining further as the number of vaccine doses increased.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg, South Africa.
- Right to Care, Pretoria, South Africa.
- Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
- National Department of Health, Pretoria, South Africa.
- Council for Scientific and Industrial Research, Pretoria, South Africa.
ORCID-Profile: Lucille Blumberg
Förderung
- NICD
- NDoH
- US Agency for International Development
Zitieren
APA
Jassat, W., Abdool Karim, S. S., Ozougwu, L., Welch, R., Mudara, C., Masha, M., Rousseau, P., Wolmarans, M., Selikow, A., Govender, N., Walaza, S., von Gottberg, A., Wolter, N., Terrence Pisa, P., Sanne, I., Govender, S., Blumberg, L., Cohen, C., Groome, M. J., & DATCOV Author Group (2023). Trends in Cases, Hospitalizations, and Mortality Related to the Omicron BA.4/BA.5 Subvariants in South Africa. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac921
Vancouver
Jassat W, Abdool Karim SS, Ozougwu L, Welch R, Mudara C, Masha M, et al. Trends in Cases, Hospitalizations, and Mortality Related to the Omicron BA.4/BA.5 Subvariants in South Africa. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac921
BibTeX
@article{Jassat2023,
author = {Jassat, Waasila and Abdool Karim, Salim S and Ozougwu, Lovelyn and Welch, Richard and Mudara, Caroline and Masha, Maureen and Rousseau, Petro and Wolmarans, Milani and Selikow, Anthony and Govender, Nevashan and Walaza, Sibongile and von Gottberg, Anne and Wolter, Nicole and Terrence Pisa, Pedro and Sanne, Ian and Govender, Sharlene and Blumberg, Lucille and Cohen, Cheryl and Groome, Michelle J and DATCOV Author Group, DATCOV Author Group},
title = {Trends in Cases, Hospitalizations, and Mortality Related to the Omicron BA.4/BA.5 Subvariants in South Africa},
journal = {Clinical Infectious Diseases},
year = {2023},
doi = {10.1093/cid/ciac921}
}
EUVIMED